BITT Announces FDA Acceptance of IND for TNFR2 Antibody
Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage biotechnology company developing novel tumor necrosis factor superfamily receptor (TNFSR) antagonist antibodies, announced today that the Food and Drug Administration (FDA) has cleared BITT’s Investigational New Drug application (IND) for…
Immunis is a Finalist for the High Tech Award for “Best Emerging Technology Company”
Immunis, Inc., a private biotech and a leading innovator in cellular secretome therapies for age and disease-related immune decline, is honored to be selected as a finalist for the “Best Emerging Technology Company” by the Octane High Tech Awards (HTA). The HTA awards…
Novartis Completes Acquisition of Chinook Therapeutics
Novartis today announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for kidney diseases, in a transaction valued at up to USD…
Novartis remibrutinib Phase III trials met their primary endpoints and showed rapid symptom control in chronic spontaneous urticaria
Novartis today announced positive top-line results from the Phase III REMIX-1 and REMIX-2 studies evaluating remibrutinib 25 mg b.i.d., a Bruton’s tyrosine kinase (BTK) inhibitor, in patients with chronic spontaneous urticaria (CSU) whose symptoms are inadequately controlled by H1-antihistamines1. Both…
Highlighting our community health work in Southern California
The 2022 Kaiser Permanente Southern California Community Health Snapshot highlights our commitment to enhancing community health by addressing social factors that influence well-being and expanding access to care. In 2022, Kaiser Permanente invested $906 million in our Southern California communities. The funding…
Aetna and March of Dimes collaborate to address food insecurity in Atlanta
Aetna Better Health® of Georgia, a CVS Health® company (NYSE: CVS), announced that Aetna® has provided a community investment of $40,000 to March of Dimes. The investment will contribute to a pop-up grocery market, in partnership with Goodr, serving pregnant and…
Aetna partners with Oral Health Kansas to support access to dental care for all
Aetna Better Health® of Kansas today announced that Aetna® has donated $30,000 to Oral Health Kansas, Inc., to help support its Pathways to Oral Health: Education Initiatives for Accessible Dental Care (Pathways) program aimed at increasing dental care for individuals with…
Henry Schein Opens Customer Assistance Hotline in Response to Hawaii Wildfires
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Hawaii that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the recent wildfires. The toll-free…
Henry Schein Launches New Equipment Repair Subscription Program
Henry Schein, Inc. (Nasdaq: HSIC) today announced the launch of its new equipment repair subscription offering – Henry Schein Thrive Service Plus, delivered by ServiceFirst – the newest addition to the exclusive portfolio of benefits and value offered as part of…
Doximity Announces Fiscal 2024 First Quarter Financial Results
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 first quarter ended June 30, 2023. “We’re pleased to report another quarter of record engagement across our entire platform, with over…
Optum and Capella University Announce New Nurse Practitioner Program To Address the Growing National Need for Skilled Clinicians
Optum, a diversified health services company, and Capella University, an accredited online university, announced a new educational program designed to address the growing need for skilled, advanced practice nurses. The collaboration will pair Capella’s unique educational capabilities with Optum’s clinical…
Elevance Health Announces John Gallina to Retire as CFO
Elevance Health (NYSE: ELV) announced today that John Gallina will retire from his role as executive vice president and CFO later this year. Mark Kaye has been named executive vice president and CFO and will serve as a member of the company’s…